New warnings added on statins in US, but routine liver tests dropped
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has warned that certain cognitive effects, such as memory loss and confusion, have been reported in patients taking statins, although regulators emphasised that the adverse effects generally have not been serious and symptoms were reversed when patients stopped taking the cholesterol-lowering agents1,2.